Induced Suppression of Platelets Activity in Aneurysmal SAH Management (iSPASM)

Summary

This is a phase 1/2a, randomized, double blind, single-center study comparing standard care alone to standard care with Aggrastat in patients diagnosed with aneurysmal subarachnoid hemorrhage.

Timeline

Start

2019-01-24

Primary completion

2020-07-01

Completion

2021-07-01

Publications

• Zanaty M, Allan L, Samaniego EA, Piscopo A, Ryan E, Torner JC, Hasan D. Phase 1/2a Trial of ISPASM. Stroke. 2021 Dec;52(12):3750-3758. doi: 10.1161/STROKEAHA.121.034578. Epub 2021 Sep 2.

Drugs

Indications